TaiGen Biotechnology Co., Ltd.
17
0
0
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
1 terminated/withdrawn out of 17 trials
93.8%
+7.2% vs industry average
18%
3 trials in Phase 3/4
20%
3 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
A Phase 1 Study of ISM4808 in Healthy Adult Subjects
Role: lead
Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
Role: lead
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
Role: lead
Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection
Role: lead
To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
Role: lead
Oral Nemonoxacin in Treating Elderly Patients With CAP
Role: lead
A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
Role: lead
To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.
Role: lead
Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
Role: collaborator
Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
Role: lead
A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics
Role: lead
Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers
Role: lead
A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients
Role: lead
Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP
Role: lead
A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion
Role: lead
Clinical Study on Oral Nemonoxacin Malate Capsules
Role: lead
Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
Role: lead
All 17 trials loaded